{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:32:16Z","timestamp":1789086736383,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.sapharm.2014.02.002","type":"journal-article","created":{"date-parts":[[2014,2,15]],"date-time":"2014-02-15T05:46:16Z","timestamp":1392443176000},"page":"e99-e112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population"],"prefix":"10.1016","volume":"10","author":[{"given":"Scott A.","family":"Baggarly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Dale","family":"Magoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2014.02.002_bib1","series-title":"Health, United States, 2012","year":"2013"},{"key":"10.1016\/j.sapharm.2014.02.002_bib2","series-title":"Harrison's Principles of Internal Medicine","article-title":"Chapter 247. Hypertensive vascular disease","author":"Kotchen","year":"2012"},{"key":"10.1016\/j.sapharm.2014.02.002_bib3","series-title":"Hypertension Among Adults in the United States, 2009-2010. NCHS Data Brief, No. 107","author":"Yoon","year":"2012"},{"key":"10.1016\/j.sapharm.2014.02.002_bib4","series-title":"Defining the Burden of Heart Diseases and Stroke in Louisiana","first-page":"30","author":"Bhoi","year":"2008"},{"key":"10.1016\/j.sapharm.2014.02.002_bib5","unstructured":"National Conference of State Legislatures. Louisiana state Profile and Policy Report. Available at: http:\/\/www.ncsl.org\/issues-research\/health\/Louisiana-state-profile-and-policy-report.aspx; Accessed 12.12.13."},{"key":"10.1016\/j.sapharm.2014.02.002_bib6","series-title":"The Seventh Report of the Joint National Committee on Prevention, Evaluation and Treatment of High Blood Pressure","first-page":"9","year":"2004"},{"key":"10.1016\/j.sapharm.2014.02.002_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.sapharm.2014.02.002_bib8","series-title":"Noncompliance With Medications: An Economic Tragedy With Important Implications for Health Care Reform","year":"1994"},{"key":"10.1016\/j.sapharm.2014.02.002_bib9","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2014.02.002_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sapharm.2014.02.002_bib11","first-page":"728","article-title":"Comparing adherence and persistence across 6 chronic medication classes","volume":"15","author":"Yeaw","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.sapharm.2014.02.002_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-pharmtox-011711-113247","article-title":"Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories","volume":"52","author":"Blaschke","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.sapharm.2014.02.002_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00006842-199907000-00023","article-title":"Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study","volume":"61","author":"Irvine","year":"1999","journal-title":"Psychosom Med"},{"key":"10.1016\/j.sapharm.2014.02.002_bib14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3109\/10641969909061025","article-title":"Compliance with antihypertensive treatment","volume":"21","author":"Waeber","year":"1999","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.sapharm.2014.02.002_bib15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.amjhyper.2006.04.006","article-title":"Medication adherence and persistence as the cornerstone of effective antihypertensive therapy","volume":"19","author":"Burnier","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.sapharm.2014.02.002_bib16","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sapharm.2014.02.002_bib17","first-page":"499","article-title":"Evaluating medication adherence: which measure is right for your program?","volume":"6","author":"Fairman","year":"2000","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.sapharm.2014.02.002_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/pop.2011.0069","article-title":"Medication adherence among recipients with chronic diseases enrolled in a state Medicaid program","volume":"15","author":"Khanna","year":"2012","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.sapharm.2014.02.002_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"10","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.sapharm.2014.02.002_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0149-2918(98)80130-6","article-title":"Continuation of initial antihypertensive medication after 1 year of therapy","volume":"20","author":"Bloom","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.sapharm.2014.02.002_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","article-title":"Comparison of drug adherence rates among patients with seven different medical conditions","volume":"28","author":"Briesacher","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.sapharm.2014.02.002_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjopharm.2010.03.002","article-title":"Racial differences in medication adherence: a cross-sectional study of Medicare enrollees","volume":"8","author":"Gerber","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.sapharm.2014.02.002_bib23","first-page":"97","article-title":"Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication","volume":"26","author":"Martin","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sapharm.2014.02.002_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1524-4733.2006.00139.x","article-title":"A checklist for medication compliance and persistence studies using retrospective databases","volume":"10","author":"Peterson","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.sapharm.2014.02.002_bib25","series-title":"Louisiana Medicaid Annual Report, State Fiscal Year 2010\/11","first-page":"38","volume":"14","year":"2012"},{"key":"10.1016\/j.sapharm.2014.02.002_bib26","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Qhan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.sapharm.2014.02.002_bib27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2014.02.002_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2407-4-94","article-title":"An electronic application for rapidly calculating Charlson comorbidity score","volume":"4","author":"Hall","year":"2004","journal-title":"BMC Cancer"},{"key":"10.1016\/j.sapharm.2014.02.002_bib29","first-page":"426","article-title":"Primary nonadherence to medications in an integrated healthcare setting","volume":"18","author":"Shin","year":"2012","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.sapharm.2014.02.002_bib30","first-page":"321","article-title":"You wrote the prescription, but will it get filled?","volume":"60","author":"Cooke","year":"2011","journal-title":"J Fam Pract"},{"key":"10.1016\/j.sapharm.2014.02.002_bib31","first-page":"24","article-title":"Effect of patient comorbidities on filling of antihypertensive prescriptions","volume":"15","author":"Lagu","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.sapharm.2014.02.002_bib32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40256-013-0033-4","article-title":"A review of the efficacy and tolerability of combination amlodipine\/valsartan in non-white patients with hypertension","volume":"13","author":"Ferdinand","year":"2013","journal-title":"Am J Cardiovasc Drugs"},{"issue":"4 suppl","key":"10.1016\/j.sapharm.2014.02.002_bib33","first-page":"5211","article-title":"Critical overview of antihypertensive therapies: what is preventing us from getting there?","volume":"6","author":"Anonymous","year":"2000","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.sapharm.2014.02.002_bib34","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00228-013-1555-z","article-title":"Persistence to antihypertensive drug treatment in Swedish primary healthcare","volume":"69","author":"Qvarnstr\u00f6m","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2014.02.002_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.sapharm.2014.02.002_bib36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1524-4733.2003.65269.x","article-title":"Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes","volume":"6","author":"Cramer","year":"2003","journal-title":"Value Health"},{"key":"10.1016\/j.sapharm.2014.02.002_bib37","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1001\/jama.288.22.2880","article-title":"Helping patients follow prescribed treatment: clinical applications","volume":"288","author":"Haynes","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.sapharm.2014.02.002_bib38","first-page":"676","article-title":"Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data","volume":"48","author":"Caro","year":"1990","journal-title":"J Clin Pharmacol Ther"},{"key":"10.1016\/j.sapharm.2014.02.002_bib39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bmj.323.7314.647","article-title":"Daily regimen and compliance with treatment","volume":"323","author":"Bloom","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2014.02.002_bib40","first-page":"e267","article-title":"Persistence with hypertension treatment among community-dwelling BC seniors","volume":"11","author":"Morgan","year":"2004","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2014.02.002_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jash.2012.02.004","article-title":"Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based network","volume":"6","author":"Ishisaka","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.sapharm.2014.02.002_bib42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0895-7061(97)00056-3","article-title":"The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly","volume":"10","author":"Monane","year":"1997","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.sapharm.2014.02.002_bib43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1528-1167.2008.01794.x","article-title":"Impact of nonadherence to antiepileptic drugs on healthcare utilization and costs: findings from the RANSOM study","volume":"50","author":"Faught","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.sapharm.2014.02.002_bib44","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.clinthera.2006.08.012","article-title":"Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysis","volume":"28","author":"Shenolikar","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.sapharm.2014.02.002_bib45","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1176\/appi.ajp.161.4.692","article-title":"Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia","volume":"161","author":"Gilmer","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.sapharm.2014.02.002_bib46","first-page":"34","article-title":"Predictors of compliance with antihypertensive therapy in a high-risk Medicaid population","volume":"101","author":"Shaya","year":"2009","journal-title":"J Natl Med Assoc"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741114000266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741114000266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:09:23Z","timestamp":1761556163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741114000266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1551741114000266"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2014.02.002","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2014.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}